Product Information
Flumatinib mesylate is a growth factor that binds to the c-Met receptor and inhibits cellular proliferation. It has been shown to be a potent inhibitor of the c-Met receptor, which may prevent the activation of downstream signal transduction pathways that cause cancer cells to grow. Flumatinib mesylate is used in combination with other medicines for the treatment of myelogenous leukemias and healthy Chinese patients with renal cell carcinoma. Flumatinib mesylate has been shown to have a genotoxic impurity effect on cells and it is structurally similar to imatinib, an anticancer drug that inhibits platelet-derived growth factor receptors.
Chemical properties
Technical inquiry about: 3D-VKB51991 Flumatinib mesylate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
